PepDiana
Back to Evidence
Paper-scoped peptide mentionSequence reported

P1

PMC12947397::PEP000001

Source publication

Effect of the antimicrobial peptide BmKn2-7 in inhibiting Vibrio parahaemolyticus and its role in improving microbiota, immunity and Vibrio resistance in Litopenaeus vannamei.

BMC Veterinary Research · 2026

DOI 10.1186/s12917-025-05264-zPMC12947397PMID 41540432
Sequence status
reported
Standardization
Sequence ready
Source location
unknown
Activity records
2

Sequence evidence

Reported molecular identity

FIKRIARLLRKIF

FIKRIARLLRKIF

Resolved peptide links

PEPDIA-PLP-003501CTPDB_P064110

Experimental observations

Records linked to this mention

AntimicrobialAntibacterialPositive observation
Record detail

The MIC of BmKn2-7 was determined to be 125 µg/mL (Table 3). The lowest concentration of BmKn2-7 without visible growth of test organisms was defined as the MIC.

Mention PMC12947397::PEP000001PMC12947397text
Measure
MIC
Value
125 µg/mL
Target
Vibrio parahaemolyticus
Assay
Not reported by source
Source publication
AntimicrobialAntibacterialPositive observation
Record detail

The cumulative survival rate of the AMP group was higher than that of the VP group (P < 0.05) and lower than that of the CG group (P < 0.05).

Mention PMC12947397::PEP000001PMC12947397text
Measure
survival_rate
Value
The cumulative survival rate of the AMP group was higher than that of the VP group (P < 0.05) and lower than that of the CG group (P < 0.05).
Target
Litopenaeus vannamei
Assay
Not reported by source
Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.